Noubar B. Afeyan, Ph.D., is a Lebanese-Armenian-American businessman, the self-made billionaire Co-founder and Chairman of Moderna (NASDAQ: MRNA) and Founder and CEO of Flagship Pioneering, a major life sciences venture creation firm. His career is rooted in elite chemical engineering, biotechnology, and serial entrepreneurial disruption.

Afeyan holds a B.S. in Chemical Engineering from McGill University (1983) and a Ph.D. in Biochemical Engineering from the Massachusetts Institute of Technology (MIT) (1987). His philosophical approach centers on radical innovation, platform creation, and long-term commitment to systemic change (inventing companies that solve major human problems).

• Moderna (Co-founder & Chairman): The core publicly traded asset, the pioneering mRNA vaccine company (a global leader in COVID-19 and other vaccine development).
• Flagship Pioneering (Founder & CEO): His core private asset, a venture creation firm that invents and funds foundational life science companies (launching over 100 ventures).
• Academic Background: He holds a Ph.D. from MIT and a B.S. from McGill University (Engineering).
• Philanthropy: He co-founded the Aurora Prize for Awakening Humanity (a major global humanitarian award) and supports Armenian causes.

Dr. Noubar Afeyan's strategic genius was his commitment to building companies around disruptive platforms. He founded Flagship Pioneering in 2000 (initially as Flagship Ventures), recognizing the structural potential of venture creation (inventing companies in-house). 2010: Moderna. He co-founded Moderna, focusing on the Messenger RNA (mRNA) platform—a contrarian, high-risk bet that became foundational to the global COVID-19 vaccine response.

His structural contribution is immense: pioneering the venture creation model in life sciences and accelerating the development of mRNA technology. His wealth surged dramatically in 2020 due to the success of the Moderna vaccine. His wealth is secured by his long-term equity stake in the publicly traded company and his vast portfolio of life science ventures.

Dr. Noubar Afeyan's social impact is massive and humanitarian, tied to Moderna's role in developing a life-saving vaccine for the global pandemic. His Flagship Pioneering funds research that addresses major human health challenges. His co-founding of the Aurora Prize provides a major structural contribution to global humanitarianism (recognizing those who risk their lives to save others).

His structural contribution is tied to his belief in radical innovation and the power of science and entrepreneurship to achieve systemic change.

Dr. Noubar Afeyan maintains the professional, composed style of a technology executive. His attire is consistently formal and high-quality, favoring tailored suits. His aesthetic reflects serious authority and stability, typical of a pioneer in the specialized biotech sector.

Residing in Boston, Massachusetts, his luxury is the immense security and financial reward derived from his multi-billion dollar fortune. His life is dedicated to biotechnology innovation, venture creation, and humanitarian philanthropy.